إعلان
إعلان

BNTX

BNTX logo

BioNTech SE - ADR

98.06
USD
برعاية
+1.22
+1.25%
٠٦ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

97.89

-0.17
-0.17%

تقارير أرباح BNTX

النسبة الإيجابية المفاجئة

BNTX تفوق 17 من 25 آخر التقديرات.

68%

التقرير التالي

بيانات التقرير القادم
١٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$818.49M
/
-$0.01
التغير الضمني من Q3 25 (Revenue/ EPS)
-46.11%
/
-91.67%
التغير الضمني من Q4 24 (Revenue/ EPS)
-31.22%
/
-100.93%

BioNTech SE - ADR earnings per share and revenue

On ٠٣ نوفمبر ٢٠٢٥, BNTX reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 44.42% surprise. Revenue reached 1.52 مليار, compared to an expected 979.55 مليون, with a 55.06% difference. The market reacted with a +0.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 المحللين forecast an EPS of -0.01 USD, with revenue projected to reach 818.49 مليون USD, implying an نقصان of -91.67% EPS, and نقصان of -46.11% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
For Q3 2025, BioNTech SE - ADR reported EPS of -$0.12, beating estimates by 44.42%, and revenue of $1.52B, 55.06% above expectations.
The stock price moved up 0.04%, changed from $103.91 before the earnings release to $103.95 the day after.
The next earning report is scheduled for ١٠ مارس ٢٠٢٦.
Based on 18 المحللين, BioNTech SE - ADR is expected to report EPS of -$0.01 and revenue of $818.49M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان